Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.

The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the world understands ultra-processed foods, after more than 90 independent food ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

UBS analyst Joseph Spak reduced his first-quarter delivery target to 367,000 vehicles from 437,000. Whitecap Resources and Veren have agreed to combine their companies in $10.44 billion deal that will ...

The European stock markets closed lower in Monday trading as The Stoxx Europe 600 fell 1.1%, Germany's DAX dropped 1.53%, the FTSE 100 in London was down 0.78%, France's CAC 40 declined 0.69%, and the ...

Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to enter the ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price ...

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...

An increasing share of the population is living in retirement for longer periods of time, offering "specific market ...

UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00.Discover the ...

On Wednesday, Bernstein SocGen Group maintained their Market Perform rating on Novo Nordisk (CSE:NOVOb) (NOVOB:DC) (NYSE: NYSE:NVO) shares, along with a price target of DKK620.00. The pharmaceutical ...